| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SAHNI PAYAL | Executive Vice President | 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK | /s/ Shanice A. Reid, by power of atty, for Payal Sahni | 27 Feb 2026 | 0001817124 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Options Exercise | $1,923,952 | +56,888 | +219% | $33.82 | 82,816 | 25 Feb 2026 | Direct | F1 |
| transaction | PFE | Common Stock | Tax liability | $29,338 | -1,083 | -1.3% | $27.09 | 81,733 | 25 Feb 2026 | Direct | F2 |
| transaction | PFE | Common Stock | Tax liability | $1,455,457 | -54,066 | -66% | $26.92 | 27,667 | 25 Feb 2026 | Direct | F3, F4 |
| holding | PFE | Common Stock | 14,630 | 25 Feb 2026 | By Rule 16b-3 Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -56,888 | -100% | $0.000000 | 0 | 25 Feb 2026 | Common Stock | 56,888 | $33.82 | Direct |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| F3 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F4 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |